돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 256315생성일: 2026년 10월 26일

Ciprofloxacin → 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid

https://huagongshe.com/reaction/256315

반응식

참여 물질

역할이름HCID투입량
반응물CiprofloxacinHCID 2764—
반응물Potassium BicarbonateHCID 516893—
반응물4-(Bromomethyl)-5-methyl-1,3-dioxol-2-oneHCID 10774141—
용매DimethylformamideHCID 6228—
생성물1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acidHCID 13673272—

반응 단계

1.15 g (3.5 mmoles) of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid are stirred in 20 ml of dimethylformamide with 0.85 g (4.4 mmoles) of 4-bromomethyl-5-methyl-1,3-dioxol-2-one and 0.42 g (4.2 mmoles) of powdered potassium bicarbonate for 3 days, while cooling with ice. The mixture is concentrated in vacuo, the residue is stirred with 20 ml of water, the resulting greasy product is dissolved in methanol and the solution is filtered. The filtrate is left to stand at room temperature for 2 days and the colorless crystals which have precipitated are isolated.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04703047
출처 데이터셋uspto-grants-1987_10
ORD IDord-a73071cede0544c8b4b53d87ab259d7d
출처 메모uspto-grants-1987_10